Shuanghuanglian Oral Liquid Market

Shuanghuanglian oral liquid is composed of honeysuckle, scutellaria root, and forsythia. Chinese medicine believes that these three flavors of Chinese medicine have a good effect of clearing away heat and detoxifying, and clearing both inside and outside. Modern medical research believes that Shuanghuanglian oral liquid has the functions of broad-spectrum antiviral, bacteriostatic and improves the body's immune function, and is one of the currently effective broad-spectrum antiviral drugs.

Shuanghuanglian Oral Liquid Market contains market size and forecasts of Shuanghuanglian Oral Liquid in global, including the following market information:

Global Shuanghuanglian Oral Liquid Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Shuanghuanglian Oral Liquid Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Shuanghuanglian Oral Liquid companies in 2021 (%)

The global Shuanghuanglian Oral Liquid market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

10ml Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Shuanghuanglian Oral Liquid include Ruige Pharmaceutical, TALOPH, Dongguan Asia Pharmaceutical, Harbin Pharmaceutical Group, Xinsheng Pharmaceutical, Jinjiu Pharmaceutical, Fusen Pharmaceutical, TASLY Holding and Harbin No.4 Traditional Chinese Medicine, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Shuanghuanglian Oral Liquid manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Shuanghuanglian Oral Liquid Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Shuanghuanglian Oral Liquid Market Segment Percentages, by Type, 2021 (%)

10ml

20ml

Global Shuanghuanglian Oral Liquid Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Shuanghuanglian Oral Liquid Market Segment Percentages, by Application, 2021 (%)

Adult

Children

Global Shuanghuanglian Oral Liquid Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Shuanghuanglian Oral Liquid Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Shuanghuanglian Oral Liquid revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Shuanghuanglian Oral Liquid revenues share in global market, 2021 (%)

Key companies Shuanghuanglian Oral Liquid sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Shuanghuanglian Oral Liquid sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Ruige Pharmaceutical

TALOPH

Dongguan Asia Pharmaceutical

Harbin Pharmaceutical Group

Xinsheng Pharmaceutical

Jinjiu Pharmaceutical

Fusen Pharmaceutical

TASLY Holding

Harbin No.4 Traditional Chinese Medicine

ZBD Pharmaceutical

Xiren Pharmaceutical